CtrlK
Pacira BioSciences
PCRX49
$22.69arrow_drop_up2.90%$0.64
PCRX49
$22.69
arrow_drop_up2.90%Performance History
arrow_drop_down10.28%
(-$0.78 )
| Key Stats | |
|---|---|
| Open | $22.03 |
| Prev. Close | $22.04 |
| EPS | -2.15 |
| Dividend | Non-Dividend |
| Next Earnings Date | - |
| Dividend Yield % | - |
| Market Cap | $1.05B |
| PE Ratio | - |
| LOW | HIGH | |
|---|---|---|
| Day Range | 20.34 | 23.52 |
| 52 Week Range | 11.16 | 35.95 |
Score Breakdown
Welcome to Stocklytics
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Analyst Forecast
There's no data available for Analyst Forecast
Period: -
• Predicted: -Analyst Ratings
There's no data available for Analyst Ratings
Last updated: -
• Total: -About Pacira BioSciences (PCRX)
- Sector
- Healthcare
- Industry
- Drug Manufacturers—Specialty & Generic
- CEO
- Mr. David M. Stack
- Headquarters
- Tampa
- Employees
- 715
- Exchange
- NASDAQ
Keep an eye on Pacira BioSciences
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
help
What is Pacira BioSciences 's (PCRX) price per share?
The current price per share for Pacira BioSciences (PCRX) is $22.69. The stock has seen a price change of $0.64 recently, indicating a 2.9% change. This reflects the stock's recent market performance and investor sentiment.
help
What is the 52-week high and low for Pacira BioSciences (PCRX)?
For Pacira BioSciences (PCRX), the 52-week high is $35.95, which is 58.44% from the current price. The 52-week low is $11.16, the current price is 103.32% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help
Is Pacira BioSciences (PCRX) a growth stock?
Pacira BioSciences (PCRX) has shown an average price growth of -1.65% over the past three years. It has received a score of 13 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Pacira BioSciences as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help
What is Pacira BioSciences (PCRX) stock price performance year to date (YTD)?
As of the latest data, Pacira BioSciences (PCRX) has a year-to-date price change of 20.44%. Over the past month, the stock has experienced a price change of -16.37%. Over the last three months, the change has been 14.6%. Over the past six months, the figure is 78.24%. Looking at a longer horizon, the five-year price change stands at -31.47%.
help
Is Pacira BioSciences (PCRX) a profitable company?
Pacira BioSciences (PCRX) has a net income of -$99.56M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 15.77% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $700.97M, with a revenue growth rate of 3.85%, providing insight into the company's sales performance and growth. The gross profit is $700.97M. Operating income is noted at -$73.37M. Furthermore, the EBITDA is $192.54M.
help
What is the market capitalization of Pacira BioSciences (PCRX)?
Pacira BioSciences (PCRX) has a market capitalization of $1.05B. The average daily trading volume is 22.99, indicating the stock's liquidity and investor engagement.